Obesity, hypertension and type 2 diabetes are the most common comorbidities, that lead to increased levels of inflammatory biomarkers such as interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α). This evidence concerns the gene IL6 and obesity due to melanocortin 4 receptor deficiency.